SCHEDULE 13G 0001810117 XXXXXXXX LIVE Common Shares 10/30/2025 0001783036 NewcelX Ltd. H5835A109 The Circle 6 Zurich V8 8058 Rule 13d-1(c) Clover Wolf Capital - Limited Partnership L3 0.00 343120.00 0.00 343120.00 343120.00 N 7.5 PN (1) Consists of 343,120 common shares, par value CHF 0.05 of NewcelX Ltd. (the "Common Shares"). Ms. Adi Wolf has sole voting and dispositive power over the shares held by Clover Wolf Capital - Limited Partnership. (2) Based on 4,558,378 Common Shares issued and outstanding as of October 31, 2025, as reported in the Issuer's Report of Foreign Private Issuer on Form 6-K filed with the Securities and Exchange Commission on October 29, 2025. Adi Wolf L3 0.00 343120.00 0.00 343120.00 343120.00 N 7.5 IN (1) Consists of 343,120 Common Shares. Ms. Adi Wolf has sole voting and dispositive power over the shares held by Clover Wolf Capital - Limited Partnership. (2) Based on 4,558,378 Common Shares issued and outstanding as of October 31, 2025, as reported in the Issuer's Report of Foreign Private Issuer on Form 6-K filed with the Securities and Exchange Commission on October 29, 2025. NewcelX Ltd. The Circle 6, Zurich, Switzerland 8058 (1) Ms. Adi Wolf (2) Clover Wolf Capital - Limited Partnership Each of the foregoing is referred to as a "Reporting Person" and collectively as the "Reporting Persons." The statement is being filed on behalf of the Reporting Persons. The address of the Reporting Persons is: 24 Bodenheimer St. Tel Aviv, 6200838, Israel (3) Ms. Adi Wolf is a citizen of the State of Israel. (4) Clover Wolf Capital - Limited Partnership is a partnership formed under the laws of the State of Israel. Y Each Reporting Person may be deemed to beneficially own 343,120 Common Shares. Ms. Adi Wolf has sole voting and dispositive power over the shares held by Clover Wolf Capital - Limited Partnership. 7.5%(1) (1) Based on 4,558,378 Common Shares issued and outstanding as of October 31, 2025, as reported in the Issuer's Report of Foreign Private Issuer on Form 6-K filed with the Securities and Exchange Commission on October 29, 2025. 0 343,120 0 343,120 Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. 1 Joint Filing Agreement dated November 7, 2025, by and between the Reporting Persons. Clover Wolf Capital - Limited Partnership /s/ Adi Wolf 11/07/2025 Adi Wolf /s/ Adi Wolf 11/07/2025